EFFICACY AND SAFETY OF APIXABAN COMPARED WITH WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION IN PATIENTS TAKING CONCOMITANT ASPIRIN

  • Alexander J
  • Lopes R
  • McMurray J
  • et al.
N/ACitations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

Background: Patients with atrial fibrillation (AF) frequently also have CAD or other indications for aspirin. We aim to define the efficacy and safety of apixaban in patients with AF who are taking and not taking aspirin.

Cite

CITATION STYLE

APA

Alexander, J. H., Lopes, R., McMurray, J., Atar, D., Wojdyla, D., Aylward, P., … Wallentin, L. (2012). EFFICACY AND SAFETY OF APIXABAN COMPARED WITH WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION IN PATIENTS TAKING CONCOMITANT ASPIRIN. Journal of the American College of Cardiology, 59(13), E1697. https://doi.org/10.1016/s0735-1097(12)61698-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free